Effect of Chlorhexidine Perineal Lavage Following Defecation in Post-Menopausal Women with Recurrent Urinary Tract Infection

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

A two-arm randomized control trial evaluating rates of urinary tract infection in post-menopausal women on vaginal estrogen with recurrent urinary tract infections.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 55
Maximum Age: 89
Healthy Volunteers: f
View:

• Post-menopausal female between age 55 and 89

• No post-menopausal bleeding

• Diagnosis of recurrent urinary tract infection (UTI) in the electronic health record or as two culture proven UTIs in 6 months or three culture proven UTIs in 12 months

• At least one UTI in the 6 months prior to entering the study

• Asymptomatic for UTI symptoms at the time of enrollment.

• On vaginal estrogen therapy for at least 6 weeks prior to enrollment

• Ready access to email and internet

Locations
United States
Oregon
Oregon Health & Science University
RECRUITING
Portland
Contact Information
Primary
Women's Health Research Unit Department of Ob/Gyn
whru@ohsu.edu
503-494-3666
Time Frame
Start Date: 2024-12-23
Estimated Completion Date: 2026-06
Participants
Target number of participants: 136
Treatments
Experimental: Chlorhexidine Lavage
2% chlorhexidine perineal lavage following defecation
Active_comparator: Sterile Water Lavage
Sterile water perineal lavage following defecation
Related Therapeutic Areas
Sponsors
Leads: Oregon Health and Science University

This content was sourced from clinicaltrials.gov